Apple (AAPL): Price Drives Estimate Increases But Ests Stay Below Street - Oppenheimer
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Oppenheimer analyst, Andrew Uerkwitz, reiterated his Perform rating on shares of Apple (NASDAQ: AAPL) after the company reported in-line F4Q16 results and provided mixed F1Q17 guidance.
The analyst stated: "It is hard to prove that the iPhone 7 cycle is stronger or weaker than 6s, since Apple no longer reports first weekend sales and new models are supply-constrained, which is typical for this time of the year. We believe that positive surprise for F1Q17 revenue guidance is mostly due to higher iPhone ASP. Implied Y/Y unit growth for iPhone (about 2% or 1M-2M units) in F1Q17 is in line with prior consensus and not material to support a more bullish view".
The analyst believes that the real proof of iPhone 7 cycle strength lies in March and June '17 results. Estimates increase due to better-than-expected ASP-driven guidance but FY17 remains below consensus.
Shares of Apple closed at $118.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple (AAPL) PT Raised to $148 at Macquarie; Services Segment Remains 'Underappreciated and Misunderstood'
- Carter's (CRI) PT Lowered to $105 at Oppenheimer; Reiterates Outperform
- PacWest Bancorp (PACW) PT Raised to $60.50 at FIG Partners Following 4Q Report
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Earnings
Related EntitiesAndrew Uerkwitz
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!